2022 Q1 Form 10-K Financial Statement

#000156276222000137 Filed on March 24, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 2020 Q4
Revenue $15.34M $56.72M
YoY Change 11.76% 7.77%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $387.0K $1.466M
YoY Change -23.82% -4.56%
% of Gross Profit
Depreciation & Amortization $188.0K $1.000M $320.0K
YoY Change -43.03% -23.08%
% of Gross Profit
Operating Expenses $387.0K $1.466M
YoY Change -23.82% -4.56%
Operating Profit
YoY Change
Interest Expense $963.0K $4.226M
YoY Change -23.14% -53.23%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $6.712M $27.68M $4.690M
YoY Change 6.9% 106.42%
Income Tax $1.858M $6.600M $450.0K
% Of Pretax Income 27.68% 23.85% 9.59%
Net Earnings $4.854M $21.08M $4.240M
YoY Change 1.53% 94.8%
Net Earnings / Revenue 31.64% 37.16%
Basic Earnings Per Share
Diluted Earnings Per Share $241.4K $1.055M $212.1K
COMMON SHARES
Basic Shares Outstanding 20.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $94.11M $47.73M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $18.69M $19.50M $6.347M
YoY Change -6.57% -6.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $38.86M $34.90M $39.20M
YoY Change -0.87% -10.97%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.967B $1.854B $1.502B
YoY Change 20.44% 23.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $23.64M $22.20M $20.80M
YoY Change 8.95% 6.73%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.64M $22.20M $20.80M
YoY Change 8.95% 6.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.277M $1.400M $500.0K
YoY Change 127.7% 180.0%
Total Long-Term Liabilities $2.277M $1.400M $500.0K
YoY Change 127.7% 180.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.64M $22.20M $20.80M
Total Long-Term Liabilities $2.277M $1.400M $500.0K
Total Liabilities $1.775B $1.650B $1.331B
YoY Change 21.35% 23.99%
SHAREHOLDERS EQUITY
Retained Earnings -$119.4M -$53.62M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $192.0M $203.9M $171.0M
YoY Change
Total Liabilities & Shareholders Equity $1.967B $1.854B $1.502B
YoY Change 20.44% 23.45%

Cashflow Statement

Concept 2022 Q1 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $4.854M $21.08M $4.240M
YoY Change 1.53% 94.8%
Depreciation, Depletion And Amortization $188.0K $1.000M $320.0K
YoY Change -43.03% -23.08%
Cash From Operating Activities $5.603M $22.05M -$1.400M
YoY Change 38.04% 68.3%
INVESTING ACTIVITIES
Capital Expenditures $155.0K $633.0K -$80.00K
YoY Change -15.76% 82.42%
Acquisitions
YoY Change
Other Investing Activities -$80.58M -$358.7M -$143.2M
YoY Change 6.42% 101.05%
Cash From Investing Activities -$80.74M -$359.4M -$143.3M
YoY Change 6.37% 101.01%
FINANCING ACTIVITIES
Cash Dividend Paid $2.077M
YoY Change -33.58%
Common Stock Issuance & Retirement, Net $102.0K $39.83M
YoY Change 265406.67%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $123.0M $335.8M 15.02M
YoY Change -5.41% 89.01%
NET CHANGE
Cash From Operating Activities $5.603M $22.05M -1.400M
Cash From Investing Activities -$80.74M -$359.4M -143.3M
Cash From Financing Activities $123.0M $335.8M 15.02M
Net Change In Cash $47.89M -$1.506M -129.7M
YoY Change -17.73% -112.56%
FREE CASH FLOW
Cash From Operating Activities $5.603M $22.05M -$1.400M
Capital Expenditures $155.0K $633.0K -$80.00K
Free Cash Flow $5.448M $21.42M -$1.320M
YoY Change 40.59% 67.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001901637
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2020 uscb Loan Settlement
LoanSettlement
USD
CY2020 uscb Preferred Stock Exchange And Redemption
PreferredStockExchangeAndRedemption
USD
CY2020 us-gaap Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax
USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2020 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
USD
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
USD
CY2020 us-gaap Payments To Acquire Loans And Leases Held For Investment
PaymentsToAcquireLoansAndLeasesHeldForInvestment
USD
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2021 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
USD
CY2020 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
USD
CY2021 uscb Proceeds From Federal Home Loan Bank Advances1
ProceedsFromFederalHomeLoanBankAdvances1
USD
CY2021 uscb Repayments On Federal Home Loan Bank Advances
RepaymentsOnFederalHomeLoanBankAdvances
USD
CY2020 uscb Transfer Of Securities Available For Sale To Securities Held For Sale
TransferOfSecuritiesAvailableForSaleToSecuritiesHeldForSale
USD
CY2020 uscb Transfer Of Property And Equipment To Assets Held For Sale
TransferOfPropertyAndEquipmentToAssetsHeldForSale
USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
USD
CY2020Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
USD
CY2020 uscb Preferred Stock Exchange And Redemption
PreferredStockExchangeAndRedemption
USD
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
USD
CY2020Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
USD
CY2021 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
USD
CY2020 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
USD
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2022Q1 dei Entity Public Float
EntityPublicFloat
268100000 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20000753 shares
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14185000 USD
CY2021Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
6477000 USD
CY2021 dei Auditor Location
AuditorLocation
Fort Lauderdale, Florida
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-9561000 USD
CY2021 dei Auditor Name
AuditorName
Crowe LLP
CY2021 dei Auditor Firm
AuditorFirmId
173
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9828000 USD
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
39751000 USD
CY2020Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
37906000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46228000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47734000 USD
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120157000 USD
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
122658000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
401542000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
334322000 USD
CY2021Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2100000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2711000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15057000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15086000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1175024000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1023418000 USD
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
5975000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
5547000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5278000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6347000 USD
CY2021Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
41720000 USD
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
25961000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
34929000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
39159000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14185000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14513000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
4300000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
2030000 USD
CY2021Q4 us-gaap Assets
Assets
1853939000 USD
CY2020Q4 us-gaap Assets
Assets
1501742000 USD
CY2021Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
605425000 USD
CY2020Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
442467000 USD
CY2021Q4 uscb Deposits Money Market And Savings Deposits
DepositsMoneyMarketAndSavingsDeposits
703856000 USD
CY2020Q4 uscb Deposits Money Market And Savings Deposits
DepositsMoneyMarketAndSavingsDeposits
527373000 USD
CY2021Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
55878000 USD
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
45132000 USD
CY2021Q4 uscb Time Deposits250000 Or More
TimeDeposits250000OrMore
119401000 USD
CY2020Q4 uscb Time Deposits250000 Or More
TimeDeposits250000OrMore
104140000 USD
CY2021Q4 uscb Time Deposits Less Than250000
TimeDepositsLessThan250000
105819000 USD
CY2020Q4 uscb Time Deposits Less Than250000
TimeDepositsLessThan250000
154290000 USD
CY2021Q4 us-gaap Deposits
Deposits
1590379000 USD
CY2020Q4 us-gaap Deposits
Deposits
1273402000 USD
CY2021Q4 uscb Advances Federal Home Loan Bank
AdvancesFederalHomeLoanBank
36000000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14513000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1330741000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
310666000 USD
CY2020Q4 uscb Advances Federal Home Loan Bank
AdvancesFederalHomeLoanBank
36000000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
177755000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124245000 USD
CY2021Q4 uscb Accrued Interest And Other Liabilities
AccruedInterestAndOtherLiabilities
9478000 USD
CY2020Q4 uscb Accrued Interest And Other Liabilities
AccruedInterestAndOtherLiabilities
6826000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1650042000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53622000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2516000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4781000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
203897000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
171001000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1853939000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1501742000 USD
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
48730000 USD
CY2020 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
47078000 USD
CY2021 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
7886000 USD
CY2020 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
5248000 USD
CY2021 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
106000 USD
CY2020 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
307000 USD
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
56722000 USD
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
52633000 USD
CY2021 uscb Interest Expense Interest Bearing Deposits
InterestExpenseInterestBearingDeposits
59000 USD
CY2020 uscb Interest Expense Interest Bearing Deposits
InterestExpenseInterestBearingDeposits
158000 USD
CY2021 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
2082000 USD
CY2020 us-gaap Interest Expense Now Accounts Money Market Accounts And Savings Deposits
InterestExpenseNOWAccountsMoneyMarketAccountsAndSavingsDeposits
3095000 USD
CY2021 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
1531000 USD
CY2020 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
4709000 USD
CY2021 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
554000 USD
CY2020 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
1074000 USD
CY2021 us-gaap Interest Expense
InterestExpense
4226000 USD
CY2020 us-gaap Interest Expense
InterestExpense
9036000 USD
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
52496000 USD
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
43597000 USD
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
160000 USD
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-3250000 USD
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
52656000 USD
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
40347000 USD
CY2021 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
3609000 USD
CY2020 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
3266000 USD
CY2021 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
214000 USD
CY2020 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
434000 USD
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1626000 USD
CY2020 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
839000 USD
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
983000 USD
CY2021 uscb Loan Settlement
LoanSettlement
2500000 USD
CY2021 us-gaap Noninterest Income Other
NoninterestIncomeOther
1766000 USD
CY2020 us-gaap Noninterest Income Other
NoninterestIncomeOther
1558000 USD
CY2021 us-gaap Noninterest Income
NoninterestIncome
10698000 USD
CY2020 us-gaap Noninterest Income
NoninterestIncome
6097000 USD
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
21438000 USD
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
19204000 USD
CY2021 us-gaap Occupancy Net
OccupancyNet
5257000 USD
CY2020 us-gaap Occupancy Net
OccupancyNet
5656000 USD
CY2021 uscb Regulatory Assessment And Fees
RegulatoryAssessmentAndFees
783000 USD
CY2020 uscb Regulatory Assessment And Fees
RegulatoryAssessmentAndFees
691000 USD
CY2021 us-gaap Legal Fees
LegalFees
1454000 USD
CY2020 us-gaap Legal Fees
LegalFees
1045000 USD
CY2021 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
1466000 USD
CY2020 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
1536000 USD
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
5279000 USD
CY2020 us-gaap Other Noninterest Expense
OtherNoninterestExpense
4904000 USD
CY2021 us-gaap Noninterest Expense
NoninterestExpense
35677000 USD
CY2020 us-gaap Noninterest Expense
NoninterestExpense
33036000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27677000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13408000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6600000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2588000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
21077000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
10820000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
10820000 USD
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2077000 USD
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3127000 USD
CY2021 uscb Preferred Stock Exchange And Redemption
PreferredStockExchangeAndRedemption
89585000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70585000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7693000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
21077000 USD
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4175000 USD
CY2021 us-gaap Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax
108000 USD
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
214000 USD
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
434000 USD
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-2370000 USD
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
917000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7297000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2824000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13780000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13644000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
171001000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
21077000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7297000 USD
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2077000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
6174000 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
39826000 USD
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
18920000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
287000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
203897000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
160282000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
10820000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2824000 USD
CY2020 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3127000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
187000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
21077000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
10820000 USD
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-160000 USD
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3250000 USD
CY2021 uscb Depreciation And Amortization1
DepreciationAndAmortization1
1033000 USD
CY2020 uscb Depreciation And Amortization1
DepreciationAndAmortization1
1272000 USD
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-596000 USD
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-358000 USD
CY2021 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
3754000 USD
CY2020 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
2661000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
287000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
187000 USD
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
214000 USD
CY2020 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
434000 USD
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1626000 USD
CY2020 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
839000 USD
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
983000 USD
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
759000 USD
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
712000 USD
CY2021 uscb Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-6600000 USD
CY2020 uscb Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-2588000 USD
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
428000 USD
CY2020 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1998000 USD
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2270000 USD
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-473000 USD
CY2021 uscb Increase Decrease In Accrued Interest And Other Liabilities
IncreaseDecreaseInAccruedInterestAndOtherLiabilities
2652000 USD
CY2020 uscb Increase Decrease In Accrued Interest And Other Liabilities
IncreaseDecreaseInAccruedInterestAndOtherLiabilities
798000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22051000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13102000 USD
CY2021 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
57917000 USD
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
3736000 USD
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
258767000 USD
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
55169000 USD
CY2021 us-gaap Payments To Acquire Loans And Leases Held For Investment
PaymentsToAcquireLoansAndLeasesHeldForInvestment
129531000 USD
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
253993000 USD
CY2021 uscb Proceeds From Maturities And Prepayments Of Available For Sale Securities
ProceedsFromMaturitiesAndPrepaymentsOfAvailableForSaleSecurities
61047000 USD
CY2020 uscb Proceeds From Maturities And Prepayments Of Available For Sale Securities
ProceedsFromMaturitiesAndPrepaymentsOfAvailableForSaleSecurities
48441000 USD
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
48940000 USD
CY2021 uscb Proceeds From Calls Of Debt Securities Available For Sale
ProceedsFromCallsOfDebtSecuritiesAvailableForSale
3034000 USD
CY2020 uscb Proceeds From Calls Of Debt Securities Available For Sale
ProceedsFromCallsOfDebtSecuritiesAvailableForSale
2140000 USD
CY2021 us-gaap Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
33515000 USD
CY2020 us-gaap Payments For Proceeds From Other Loans And Leases
PaymentsForProceedsFromOtherLoansAndLeases
42527000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
633000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
347000 USD
CY2021 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
16980000 USD
CY2020 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
9295000 USD
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1652000 USD
CY2021 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
611000 USD
CY2020 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
4972000 USD
CY2020 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1926000 USD
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
15000000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-359363000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-178776000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
39826000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15000 USD
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
2077000 USD
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
3127000 USD
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
316977000 USD
CY2020 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
255779000 USD
CY2020 uscb Proceeds From Federal Home Loan Bank Advances1
ProceedsFromFederalHomeLoanBankAdvances1
79000000 USD
CY2020 uscb Repayments On Federal Home Loan Bank Advances
RepaymentsOnFederalHomeLoanBankAdvances
154000000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
335806000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
177667000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1506000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11993000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47734000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35741000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46228000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47734000 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
4286000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
8844000 USD
CY2021 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
15354000 USD
CY2020 us-gaap Transfer Of Portfolio Loans And Leases To Held For Sale1
TransferOfPortfolioLoansAndLeasesToHeldForSale1
8456000 USD
CY2021 uscb Transfer Of Securities Available For Sale To Securities Held For Sale
TransferOfSecuritiesAvailableForSaleToSecuritiesHeldForSale
68667000 USD
CY2021 uscb Transfer Of Property And Equipment To Assets Held For Sale
TransferOfPropertyAndEquipmentToAssetsHeldForSale
652000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
328000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div id="TextBlockContainer15" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:261px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18509" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Use of Estimates </div><div id="a18512" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:31px;">In preparing the consolidated financial statements, management is required<div style="display:inline-block;width:2px"> </div>to make estimates and assumptions based </div><div id="a18515" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">on available information that affect the amounts reported<div style="display:inline-block;width:5px"> </div>in the financial statements and the disclosures provided. </div><div id="a18518" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:77px;">The coronavirus (“COVID-19”)<div style="display:inline-block;width:6px"> </div>pandemic has negatively<div style="display:inline-block;width:6px"> </div>affected many of<div style="display:inline-block;width:5px"> </div>the Company’s<div style="display:inline-block;width:5px"> </div>clients and could<div style="display:inline-block;width:5px"> </div>still impair </div><div id="a18526" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:92px;">their ability to fulfill<div style="display:inline-block;width:5px"> </div>their financial obligations.<div style="display:inline-block;width:5px"> </div>The Company’s business<div style="display:inline-block;width:6px"> </div>is dependent upon the<div style="display:inline-block;width:5px"> </div>willingness and ability<div style="display:inline-block;width:5px"> </div>of its </div><div id="a18531" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:107px;">associates and customers to conduct banking and other financial transactions.<div style="display:inline-block;width:5px"> </div>While we believe conditions have improved </div><div id="a18533" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:123px;">as of December 31, 2021, if there is a resurgence in the virus, the Company could experience further adverse effects on its </div><div id="a18540" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:138px;">business,<div style="display:inline-block;width:5px"> </div>financial<div style="display:inline-block;width:5px"> </div>condition,<div style="display:inline-block;width:5px"> </div>results<div style="display:inline-block;width:5px"> </div>of operations<div style="display:inline-block;width:7px"> </div>and<div style="display:inline-block;width:5px"> </div>cash<div style="display:inline-block;width:5px"> </div>flows.<div style="display:inline-block;width:5px"> </div>While<div style="display:inline-block;width:5px"> </div>it<div style="display:inline-block;width:5px"> </div>is not<div style="display:inline-block;width:6px"> </div>possible<div style="display:inline-block;width:5px"> </div>to know<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:5px"> </div>full<div style="display:inline-block;width:5px"> </div>extent<div style="display:inline-block;width:5px"> </div>of<div style="display:inline-block;width:5px"> </div>the </div><div id="a18543" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:153px;">impact the<div style="display:inline-block;width:6px"> </div>COVID-19<div style="display:inline-block;width:5px"> </div>pandemic will<div style="display:inline-block;width:6px"> </div>have on<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:5px"> </div>Company's<div style="display:inline-block;width:5px"> </div>future operations,<div style="display:inline-block;width:6px"> </div>the Company<div style="display:inline-block;width:6px"> </div>continues<div style="display:inline-block;width:5px"> </div>to<div style="display:inline-block;width:5px"> </div>communicate </div><div id="a18546" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">with its associates and customers<div style="display:inline-block;width:5px"> </div>to understand their challenges, which<div style="display:inline-block;width:5px"> </div>allows us to respond to<div style="display:inline-block;width:5px"> </div>their needs and issues as </div><div id="a18549" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:184px;">they arise. </div><div id="a18552" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:215px;">While there was<div style="display:inline-block;width:2px"> </div>not a<div style="display:inline-block;width:2px"> </div>material impact to<div style="display:inline-block;width:2px"> </div>the Company’s Consolidated Financial<div style="display:inline-block;width:2px"> </div>Statements as of<div style="display:inline-block;width:2px"> </div>and for<div style="display:inline-block;width:2px"> </div>the year ended </div><div id="a18563" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:230px;">December 31, 2021,<div style="display:inline-block;width:5px"> </div>future increases<div style="display:inline-block;width:6px"> </div>in the<div style="display:inline-block;width:5px"> </div>allowance for<div style="display:inline-block;width:5px"> </div>credit losses<div style="display:inline-block;width:5px"> </div>(“ACL”) may<div style="display:inline-block;width:5px"> </div>be required<div style="display:inline-block;width:5px"> </div>because of<div style="display:inline-block;width:5px"> </div>the potential </div><div id="a18582" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:245px;">economic<div style="display:inline-block;width:5px"> </div>downturn<div style="display:inline-block;width:5px"> </div>that<div style="display:inline-block;width:5px"> </div>a<div style="display:inline-block;width:5px"> </div>resurgence<div style="display:inline-block;width:5px"> </div>in<div style="display:inline-block;width:5px"> </div>the virus<div style="display:inline-block;width:6px"> </div>may<div style="display:inline-block;width:5px"> </div>cause<div style="display:inline-block;width:5px"> </div>and those<div style="display:inline-block;width:6px"> </div>ACL<div style="display:inline-block;width:5px"> </div>increases<div style="display:inline-block;width:5px"> </div>can be<div style="display:inline-block;width:6px"> </div>material.<div style="display:inline-block;width:5px"> </div>It<div style="display:inline-block;width:5px"> </div>is difficult<div style="display:inline-block;width:6px"> </div>to </div></div><div id="TextBlockContainer19" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:32px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a18613" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:0px;">quantify the<div style="display:inline-block;width:5px"> </div>impact that<div style="display:inline-block;width:5px"> </div>COVID-19 will<div style="display:inline-block;width:5px"> </div>have on<div style="display:inline-block;width:5px"> </div>the estimates<div style="display:inline-block;width:5px"> </div>and assumptions<div style="display:inline-block;width:6px"> </div>used to<div style="display:inline-block;width:5px"> </div>prepare the<div style="display:inline-block;width:5px"> </div>financial statements. </div><div id="a18616" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:15px;">Actual results could differ from those estimates.</div></div>
CY2021Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2100000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
2700000 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id="TextBlockContainer44" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:430px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19209" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Concentration of Credit Risks </div><div id="a19212" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:31px;">Credit<div style="display:inline-block;width:5px"> </div>risk<div style="display:inline-block;width:5px"> </div>represents<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>accounting<div style="display:inline-block;width:6px"> </div>loss<div style="display:inline-block;width:5px"> </div>that<div style="display:inline-block;width:5px"> </div>would<div style="display:inline-block;width:6px"> </div>be<div style="display:inline-block;width:5px"> </div>recognized<div style="display:inline-block;width:6px"> </div>at<div style="display:inline-block;width:5px"> </div>the<div style="display:inline-block;width:5px"> </div>reporting<div style="display:inline-block;width:6px"> </div>date<div style="display:inline-block;width:5px"> </div>if<div style="display:inline-block;width:5px"> </div>counterparties<div style="display:inline-block;width:6px"> </div>failed<div style="display:inline-block;width:5px"> </div>to </div><div id="a19213" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">perform as contracted and any collateral or security proved to be insufficient<div style="display:inline-block;width:5px"> </div>to cover the loss. Concentrations of credit risk </div><div id="a19215" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:61px;">(whether on or off-balance sheet) arising from financial instruments exist in relation to certain<div style="display:inline-block;width:2px"> </div>groups of customers. A group </div><div id="a19218" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:77px;">concentration arises when<div style="display:inline-block;width:6px"> </div>a number of<div style="display:inline-block;width:5px"> </div>counterparties have<div style="display:inline-block;width:5px"> </div>similar economic characteristics<div style="display:inline-block;width:6px"> </div>that would cause<div style="display:inline-block;width:5px"> </div>their ability </div><div id="a19220" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:92px;">to meet contractual obligations to be similarly affected by changes in economic or other conditions. The Company does not </div><div id="a19221" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:107px;">have a significant exposure to any individual customer<div style="display:inline-block;width:5px"> </div>or counterparty. </div><div id="a19225" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:138px;">Most of the Company's business activity is<div style="display:inline-block;width:2px"> </div>with customers located within its primary market area, which<div style="display:inline-block;width:2px"> </div>is generally the </div><div id="a19226" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:153px;">State of Florida. The Company's loan portfolio is concentrated largely in real estate and commercial loans in South Florida. </div><div id="a19228" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:169px;">Many of the Company's<div style="display:inline-block;width:5px"> </div>loan customers are engaged<div style="display:inline-block;width:5px"> </div>in real estate development.<div style="display:inline-block;width:6px"> </div>Circumstances, which negatively<div style="display:inline-block;width:5px"> </div>impact </div><div id="a19229" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:184px;">the South Florida real estate industry<div style="display:inline-block;width:2px"> </div>or the South Florida economy, in general, could adversely impact<div style="display:inline-block;width:2px"> </div>the Company's loan </div><div id="a19231" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:199px;">portfolio. </div><div id="a19234" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:230px;">At December 31,<div style="display:inline-block;width:6px"> </div>2021 and<div style="display:inline-block;width:6px"> </div>2020, the<div style="display:inline-block;width:5px"> </div>Company had<div style="display:inline-block;width:6px"> </div>a concentration<div style="display:inline-block;width:6px"> </div>of risk<div style="display:inline-block;width:5px"> </div>with loans<div style="display:inline-block;width:6px"> </div>outstanding to<div style="display:inline-block;width:6px"> </div>the Company’s </div><div id="a19237" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:245px;">top ten lending relationships<div style="display:inline-block;width:5px"> </div>totaling $</div><div id="a19237_40_5" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:230px;top:245px;">156.4</div><div id="a19237_45_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:263px;top:245px;"><div style="display:inline-block;width:4px"> </div>million and $</div><div id="a19237_59_5" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:342px;top:245px;">141.5</div><div id="a19237_64_60" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:376px;top:245px;"><div style="display:inline-block;width:4px"> </div>million, respectively.<div style="display:inline-block;width:6px"> </div>At December 31, 2021 and<div style="display:inline-block;width:5px"> </div>2020, this </div><div id="a19249" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:261px;">concentration represented </div><div id="a19249_26_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:164px;top:261px;">13.1</div><div id="a19249_30_6" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:189px;top:261px;">% and </div><div id="a19249_36_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:231px;top:261px;">13.6</div><div id="a19249_40_48" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:257px;top:261px;">%, respectively,<div style="display:inline-block;width:5px"> </div>of the net loans outstanding.<div style="display:inline-block;width:5px"> </div></div><div id="a19259" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:291px;">At December 31,<div style="display:inline-block;width:6px"> </div>2021, the<div style="display:inline-block;width:5px"> </div>Company also<div style="display:inline-block;width:5px"> </div>had a<div style="display:inline-block;width:5px"> </div>concentration of<div style="display:inline-block;width:6px"> </div>risk with<div style="display:inline-block;width:5px"> </div>loans outstanding<div style="display:inline-block;width:6px"> </div>totaling $</div><div id="a19259_100_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:641px;top:291px;">47.9</div><div id="a19259_104_12" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:667px;top:291px;"><div style="display:inline-block;width:4px"> </div>million to </div><div id="a19268" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:307px;">foreign<div style="display:inline-block;width:8px"> </div>banks<div style="display:inline-block;width:8px"> </div>located<div style="display:inline-block;width:8px"> </div>in<div style="display:inline-block;width:8px"> </div>Ecuador,<div style="display:inline-block;width:9px"> </div>Honduras,<div style="display:inline-block;width:8px"> </div>and<div style="display:inline-block;width:8px"> </div>El<div style="display:inline-block;width:8px"> </div>Salvador.<div style="display:inline-block;width:9px"> </div>At<div style="display:inline-block;width:8px"> </div>December 31,<div style="display:inline-block;width:8px"> </div>2020,<div style="display:inline-block;width:8px"> </div>the<div style="display:inline-block;width:8px"> </div>Company<div style="display:inline-block;width:8px"> </div>also<div style="display:inline-block;width:8px"> </div>had<div style="display:inline-block;width:8px"> </div>a </div><div id="a19277" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:322px;">concentration of<div style="display:inline-block;width:6px"> </div>risk with<div style="display:inline-block;width:6px"> </div>loans outstanding<div style="display:inline-block;width:6px"> </div>totaling<div style="display:inline-block;width:5px"> </div>$</div><div id="a19277_55_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:325px;top:322px;">38.8</div><div id="a19277_59_63" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:350px;top:322px;"><div style="display:inline-block;width:5px"> </div>million to<div style="display:inline-block;width:6px"> </div>foreign banks<div style="display:inline-block;width:6px"> </div>located in<div style="display:inline-block;width:6px"> </div>Ecuador,<div style="display:inline-block;width:6px"> </div>Honduras, and<div style="display:inline-block;width:6px"> </div>El </div><div id="a19284" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:337px;">Salvador.<div style="display:inline-block;width:6px"> </div>These<div style="display:inline-block;width:5px"> </div>banks<div style="display:inline-block;width:5px"> </div>maintained<div style="display:inline-block;width:5px"> </div>deposits<div style="display:inline-block;width:5px"> </div>with<div style="display:inline-block;width:5px"> </div>right<div style="display:inline-block;width:5px"> </div>of<div style="display:inline-block;width:5px"> </div>offset<div style="display:inline-block;width:5px"> </div>totaling<div style="display:inline-block;width:5px"> </div>$</div><div id="a19284_73_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:443px;top:337px;">28.9</div><div id="a19284_77_14" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:469px;top:337px;"><div style="display:inline-block;width:5px"> </div>million<div style="display:inline-block;width:5px"> </div>and<div style="display:inline-block;width:5px"> </div>$</div><div id="a19284_91_4" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:551px;top:337px;">18.2</div><div id="a19284_95_25" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:577px;top:337px;"><div style="display:inline-block;width:5px"> </div>million<div style="display:inline-block;width:5px"> </div>at<div style="display:inline-block;width:5px"> </div>December 31, </div><div id="a19293" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:353px;">2021 and 2020, respectively. </div><div id="a19298" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:383px;">At various times during<div style="display:inline-block;width:5px"> </div>the year,<div style="display:inline-block;width:5px"> </div>the Company has maintained<div style="display:inline-block;width:5px"> </div>deposits with other<div style="display:inline-block;width:5px"> </div>financial institutions. The exposure </div><div id="a19299" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:399px;">to the Company from<div style="display:inline-block;width:2px"> </div>these transactions is solely<div style="display:inline-block;width:2px"> </div>dependent upon daily balances<div style="display:inline-block;width:2px"> </div>and the financial strength<div style="display:inline-block;width:2px"> </div>of the respective </div><div id="a19301" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:414px;">institution.</div></div>
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
28900000 USD
CY2020Q4 us-gaap Escrow Deposit
EscrowDeposit
18200000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
590000 USD
CY2021Q4 us-gaap Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue
20000000.0 USD
CY2021Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
41700000 USD
CY2020Q4 uscb Percent Of Total Loans
PercentOfTotalLoans
0.998 pure
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div id="TextBlockContainer94" style="position:relative;font-family:'Arial';font-size:13.28px;color:#000000;line-height:normal;width:735px;height:62px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a19828" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:bold;font-style:normal;color:#000000;left:5px;top:0px;">Reclassifications </div><div id="a19831" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:29px;top:31px;">Certain<div style="display:inline-block;width:9px"> </div>amounts<div style="display:inline-block;width:9px"> </div>in<div style="display:inline-block;width:8px"> </div>the<div style="display:inline-block;width:9px"> </div>Consolidated<div style="display:inline-block;width:9px"> </div>Financial<div style="display:inline-block;width:9px"> </div>Statements<div style="display:inline-block;width:9px"> </div>have<div style="display:inline-block;width:9px"> </div>been<div style="display:inline-block;width:9px"> </div>reclassified<div style="display:inline-block;width:9px"> </div>to<div style="display:inline-block;width:8px"> </div>conform<div style="display:inline-block;width:9px"> </div>to<div style="display:inline-block;width:9px"> </div>the<div style="display:inline-block;width:9px"> </div>current </div><div id="a19838" style="position:absolute;font-family:'Arial';font-size:13.28px;font-weight:normal;font-style:normal;color:#000000;left:5px;top:46px;">presentation. Reclassifications had no impact on the net income<div style="display:inline-block;width:5px"> </div>or stockholders’ equity of the Company.</div></div>
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2982000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7293000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
401542000 USD
CY2021Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
122658000 USD
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
14000 USD
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2515000 USD
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120157000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
327989000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6923000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
590000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
334322000 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
51974000 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
57309000 USD
CY2021 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
545000 USD
CY2020 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
862000 USD
CY2021 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
331000 USD
CY2020 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
428000 USD
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
214000 USD
CY2020 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
434000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
422253000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
9476000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
117918000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
590000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
117918000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1992000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2036000 USD
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
2017000 USD
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
2013000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
5983000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6288000 USD
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
11293000 USD
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11076000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
31096000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
32512000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
25164000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
24398000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
405853000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
401542000 USD
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
122658000 USD
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120157000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
311459000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5381000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
110794000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4095000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1191659000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
10067000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
10045000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
360000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
11652000 USD
CY2021Q4 uscb Percent Of Total Loans
PercentOfTotalLoans
1.000 pure
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1041015000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
5833000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
5825000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1578000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
2511000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1190081000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1038504000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15057000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
15086000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1175024000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1023418000 USD
CY2021Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
185100000 USD
CY2020Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
250700000 USD
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
1200000 USD
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
0 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15086000 USD
CY2021 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
160000 USD
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
392000 USD
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
261000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15057000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
11998000 USD
CY2020 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-3250000 USD
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
494000 USD
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
656000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15086000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
360000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
14697000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15057000 USD
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
10067000 USD
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1181592000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1191659000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
453000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
14633000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
15086000 USD
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
11652000 USD
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1029363000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1041015000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1191659000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1041015000 USD
CY2021Q4 uscb Financing Receivable Including90 Days Or More Past Due Still Accruing And Excluding Non Accrual Before Allowance For Credit Loss
FinancingReceivableIncluding90DaysOrMorePastDueStillAccruingAndExcludingNonAccrualBeforeAllowanceForCreditLoss
1190469000 USD
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1190000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1191659000 USD
CY2020Q4 uscb Financing Receivable Including90 Days Or More Past Due Still Accruing And Excluding Non Accrual Before Allowance For Credit Loss
FinancingReceivableIncluding90DaysOrMorePastDueStillAccruingAndExcludingNonAccrualBeforeAllowanceForCreditLoss
1039437000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
1578000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1041015000 USD
CY2021 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 USD
CY2020 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 USD
CY2021 us-gaap Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
5000 USD
CY2020 us-gaap Interest Income Financing Receivable Before Allowance For Credit Loss
InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss
47000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
5717000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
5730000 USD
CY2020Q4 uscb Deferred Tax Assets Deferred Loan Fees
DeferredTaxAssetsDeferredLoanFees
636000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
4350000 USD
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
4315000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
360000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
5819000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
5782000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
453000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
453000 USD
CY2021 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
9937000 USD
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
8877000 USD
CY2021 us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
415000 USD
CY2020 us-gaap Loans And Leases Receivable Impaired Troubled Debt Interest Income
LoansAndLeasesReceivableImpairedTroubledDebtInterestIncome
446000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
11607000 USD
CY2021Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
8876000 USD
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
10874000 USD
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
360000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
453000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0 USD
CY2020Q4 us-gaap Loans And Leases Receivable Impaired Commitment To Lend
LoansAndLeasesReceivableImpairedCommitmentToLend
0 USD
CY2021 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
10 Item
CY2021 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
6664000 USD
CY2021 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
10 Item
CY2021 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
6660000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14185000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14513000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14185000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14513000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M10D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M17D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0232 pure
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0249 pure
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2837000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2471000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2540000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2606000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1675000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3968000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
16097000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1912000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14185000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26118000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27198000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20840000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20851000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5278000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6347000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1000000.0 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1300000 USD
CY2020 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
500000 USD
CY2021Q4 uscb Deferred Tax Assets Deferred Loan Fees
DeferredTaxAssetsDeferredLoanFees
400000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5314000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2074000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1286000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
514000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6600000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2588000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6600000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2588000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5812000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2815000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
969000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
469000 USD
CY2021 uscb Effective Income Tax Rate Reconciliation Bank Owned Life Insurance
EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance
186000 USD
CY2020 uscb Effective Income Tax Rate Reconciliation Bank Owned Life Insurance
EffectiveIncomeTaxRateReconciliationBankOwnedLifeInsurance
174000 USD
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
5000 USD
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-522000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6600000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2588000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28819000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35506000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
3816000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
3824000 USD
CY2021Q4 uscb Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3595000 USD
CY2020Q4 uscb Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3617000 USD
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
817000 USD
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
361000 USD
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
285000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
241000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
169000 USD
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
600000 USD
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
349000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38651000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44393000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
1553000 USD
CY2021Q4 uscb Deferred Tax Liability Lease Right Of Use Asset
DeferredTaxLiabilityLeaseRightOfUseAsset
3595000 USD
CY2020Q4 uscb Deferred Tax Liability Lease Right Of Use Asset
DeferredTaxLiabilityLeaseRightOfUseAsset
3617000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
127000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
64000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3722000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5234000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
34929000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
39159000 USD
CY2021Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
605425000 USD
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
442467000 USD
CY2021Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
55878000 USD
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
45132000 USD
CY2021Q4 uscb Saving And Money Market Deposits
SavingAndMoneyMarketDeposits
703856000 USD
CY2020Q4 uscb Saving And Money Market Deposits
SavingAndMoneyMarketDeposits
527373000 USD
CY2021Q4 us-gaap Time Deposits
TimeDeposits
225220000 USD
CY2020Q4 us-gaap Time Deposits
TimeDeposits
258430000 USD
CY2021Q4 us-gaap Deposits
Deposits
1590379000 USD
CY2020Q4 us-gaap Deposits
Deposits
1273402000 USD
CY2021Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
119400000 USD
CY2020Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
104100000 USD
CY2021Q4 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
184495000 USD
CY2021Q4 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
15111000 USD
CY2021Q4 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
4164000 USD
CY2021Q4 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
1172000 USD
CY2021Q4 us-gaap Time Deposit Maturities Year Five
TimeDepositMaturitiesYearFive
20271000 USD
CY2021Q4 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
7000 USD
CY2021Q4 us-gaap Time Deposits
TimeDeposits
225220000 USD
CY2021Q4 uscb Reclassification Of Time Deposits
ReclassificationOfTimeDeposits
247000 USD
CY2020Q4 uscb Reclassification Of Time Deposits
ReclassificationOfTimeDeposits
224000 USD
CY2021Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
36000000.0 USD
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
36000000.0 USD
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2020Q4 uscb Tier One Common Equity
TierOneCommonEquity
94984000 USD
CY2020Q4 uscb Excesstieronecommonequitytoriskweightedassets
Excesstieronecommonequitytoriskweightedassets
0.0971 pure
CY2020Q4 uscb Tieronecommonequityrequiredforcapitaladequacy
Tieronecommonequityrequiredforcapitaladequacy
44021000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.37
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
620000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.69
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
959667 shares
CY2021Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
36000000 USD
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
296000 USD
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
282000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
339667 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.87
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
319667 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.07
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
663000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
365667 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.30
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
24000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.17
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
339667 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.37
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
242333 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.71
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
208000 USD
CY2021Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
141297000 USD
CY2020Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
109366000 USD
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
171484000 USD
CY2021Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0955 pure
CY2021 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
2077000 USD
CY2020 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
3127000 USD
CY2021 uscb Percent Used To Calculate Income Allocation
PercentUsedToCalculateIncomeAllocation
0.20 pure
CY2020Q4 uscb Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
0.0450 pure
CY2021 us-gaap Net Income Loss
NetIncomeLoss
21077000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
10820000 USD
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2077000 USD
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3127000 USD
CY2021 uscb Preferred Stock Exchange And Redemption
PreferredStockExchangeAndRedemption
89585000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70585000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7693000 USD
CY2021Q4 us-gaap Banking Regulation Capital Conservation Buffer Capital Conserved Minimum
BankingRegulationCapitalConservationBufferCapitalConservedMinimum
0.025 pure
CY2021Q4 us-gaap Capital
Capital
186735000 USD
CY2021Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1492 pure
CY2021Q4 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
100125000 USD
CY2021Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0800 pure
CY2021Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
125157000 USD
CY2021Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000 pure
CY2021Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
171484000 USD
CY2021Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1370 pure
CY2021Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
75094000 USD
CY2021Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0600 pure
CY2021Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
100125000 USD
CY2021Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800 pure
CY2021Q4 uscb Tier One Common Equity
TierOneCommonEquity
171484000 USD
CY2021Q4 uscb Excesstieronecommonequitytoriskweightedassets
Excesstieronecommonequitytoriskweightedassets
0.1370 pure
CY2021Q4 uscb Tieronecommonequityrequiredforcapitaladequacy
Tieronecommonequityrequiredforcapitaladequacy
56321000 USD
CY2021Q4 uscb Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
Tieronecommonequityrequiredforcapitaladequacytoriskweightedassets
0.0450 pure
CY2021Q4 uscb Tieronecommonequityrequiredtobewellcapitalized
Tieronecommonequityrequiredtobewellcapitalized
81352000 USD
CY2021Q4 uscb Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
0.0650 pure
CY2021Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
71825000 USD
CY2021Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.0400 pure
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
89781000 USD
CY2021Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500 pure
CY2020Q4 us-gaap Capital
Capital
139326000 USD
CY2020Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.1424 pure
CY2020Q4 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
78260000 USD
CY2020Q4 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0800 pure
CY2020Q4 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
97825000 USD
CY2020Q4 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.1000 pure
CY2020Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
127061000 USD
CY2020Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.1299 pure
CY2020Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
58695000 USD
CY2020Q4 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.0600 pure
CY2020Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
78260000 USD
CY2020Q4 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.0800 pure
CY2020Q4 uscb Tieronecommonequityrequiredtobewellcapitalized
Tieronecommonequityrequiredtobewellcapitalized
63587000 USD
CY2020Q4 uscb Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
Tieronecommonequityrequiredtobewellcapitalizedtoriskweightedassets
0.0650 pure
CY2020Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
127061000 USD
CY2020Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.0861 pure
CY2020Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy
TierOneLeverageCapitalRequiredForCapitalAdequacy
59053000 USD
CY2020Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.0400 pure
CY2020Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
73817000 USD
CY2020Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.0500 pure
CY2021Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
1905000 USD
CY2020Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
1793000 USD
CY2021 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
16000 USD
CY2020 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
23000 USD

Files In Submission

Name View Source Status
0001562762-22-000137-index-headers.html Edgar Link pending
0001562762-22-000137-index.html Edgar Link pending
0001562762-22-000137.txt Edgar Link pending
0001562762-22-000137-xbrl.zip Edgar Link pending
exhibit102.htm Edgar Link pending
exhibit102p14i0.jpg Edgar Link pending
exhibit102p14i1.jpg Edgar Link pending
exhibit103.htm Edgar Link pending
exhibit103p1i0.jpg Edgar Link pending
exhibit104.htm Edgar Link pending
exhibit104p4i0.jpg Edgar Link pending
exhibit105.htm Edgar Link pending
exhibit105p14i0.jpg Edgar Link pending
exhibit106.htm Edgar Link pending
exhibit106p3i0.jpg Edgar Link pending
exhibit211.htm Edgar Link pending
exhibit231.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
exhibit44.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uscb-10K-20211231.htm Edgar Link pending
uscb-10K-20211231p1i0.jpg Edgar Link pending
uscb-10K-20211231p42i0.gif Edgar Link pending
uscb-10K-20211231p65i0.jpg Edgar Link pending
uscb-10K-20211231p65i1.gif Edgar Link pending
uscb-10K-20211231_htm.xml Edgar Link completed
uscb-20211231.xsd Edgar Link pending
uscb-20211231_cal.xml Edgar Link unprocessable
uscb-20211231_def.xml Edgar Link unprocessable
uscb-20211231_lab.xml Edgar Link unprocessable
uscb-20211231_pre.xml Edgar Link unprocessable